It is considered unethical for manufacturers to design prospective human trials to ascertain potential teratogenicity or to determine dangers to a baby when medications pass into breast milk. Thus, pregnant and lactating females are often referred to as therapeutic orphans. Many of these patients choose nonprescription products on their own. However, even when women do ask, pharmacists are hampered by the general lack of knowledge regarding the potential dangers of these products.
US Pharmacist. 2007;32(9):10-14. © 2007 Jobson Publishing
Cite this: Nonprescription Products for the Pregnant and Breast-Feeding Patient - Medscape - Sep 19, 2007.